Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib + T-DM1 vs T-DM1 in HER2+ Breast Cancer With Brain Metastases
NCT04158947Phase 2Unknown
- Start
- May 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of afatinib in breast cancer, brain metastases. Status: unknown.
02
Drugs
afatinib
03
Conditions
breast cancerbrain metastases
Beyond the preview
Go deeper on NCT04158947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04158947.